This information was published on 2026-07-12T00:10:06 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2626447 |
| (220) |
11 Feb 2026
|
| (500) |
It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing substances belonging to the pharmacological group designated by the International Non-Proprietary Name stem TIDE.
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations for the treatment of cardiovascular conditions; pharmaceutical preparations for the treatment of autoimmune conditions; pharmaceutical preparations for the treatment of inflammatory conditions; pharmaceutical preparations for the treatment of fibrotic diseases; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations for the treatment of metabolic conditions; topical pharmaceutical preparations |
| (540) | KESONOTIDE |
| (550) | Word |
| (730) |
Filamon Limited
ACN/ABN 630721783 |
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.